Neurohormonal status is associated with long-term appropriate implantable cardioverter defibrillator therapy for life-threatening ventricular arrhythmia

Back

ESC Professional Premium Access

Neurohormonal status is associated with long-term appropriate implantable cardioverter defibrillator therapy for life-threatening ventricular arrhythmia

Session: Risk stratification, devices, and ablation in the management of malignant ventricular arrhythmias

Topic: Cardioversion and Defibrillation

Speaker: Professor F. Beygui (Caen, FR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Farzin Beygui

University Hospital of Caen, Caen (France)

5 presentations

0 follower

7 more presentations in this session

Catheter ablation for ventricular tachycardia after myocardial infarction: meta-analysis of randomised controlled trials

Speaker: Doctor R. Reddy (London, GB)

Influence of standard modifiable risk factors on ventricular tachycardia after myocardial infarction

Speaker: Doctor T. Deshmukh (Westmead, AU)

Surpoint algorithm for improved guidance of ablation for ventricular tachycardia (SURFIRE-VT): a propensity-matched study

Speaker: Doctor D. Sanders (Chicago, US)

Association of ventricular tachycardia morphology induced on electrophysiology study after myocardial infarction: long-term survival and ventricular tachyarrhythmia recurrence

Speaker: Doctor J. Kovoor (Westmead, AU)

Sex-differences in ventricular tachyarrhythmia events in patients with implantable cardioverter defibrillator and prior ventricular tachyarrhythmias

Speaker: Doctor B. Krzowski (Warsaw, PL)

Access the full session

Risk stratification, devices, and ablation in the management of malignant ventricular arrhythmias

Speakers: Professor F. Beygui, Doctor R. Reddy, Doctor T. Deshmukh, Doctor D. Sanders, Doctor J. Kovoor...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources